Selected Scientific Papers
- Andrikoula M, Baker D, Nesic J, Liao LM, Duka T, Prelevic GM
The effects of micronutrient supplementation on vasomotor symptoms in postmenopausal women
Climacteric, 2011; 14: 544-550.
- Liao L-M, Nesic J, Chadwick P, Brooke-Wavell K & Prelevic GM
Exercise and body image distress in overweight and obese women with Polycystic Ovary Syndrome
Gynaecological Endocrinology, 2008; 24: 555-561.
- Kocjan T, Tan T, Conway G, Prelevic GM
Vitamin D status in patients with ostepenia or osteoporosis – an audit of an endocrine clinic
International Journal for Vitamin and Nutrition Research, 2006; 76: 307-313.
- Lewandowski KC, Komorowski J, Prelevic GM, Randeva HS
Effects of hormone replacement therapy, type and route of administration on plasma matrix metalloproteinases and their tissue inhibitors in postmenopausal women
Journal of Endocrinology and Metabolism, 2006; 91:3123-3130.
- Lewandowski KC, Komorowski J, Prelevic GM, Randeva HS
Increased circulating levels of matrix metalloproteinase-2 and -9 in women with Polycystic Ovary Syndrome
Journal of Endocrinology and Metabolism 2006; 91: 1173-1177.
- Agrawal R, Sharma S, Bekir J, Conway G, Bailey J, Balen AH, Prelevic GM
Prevalence of Polycystic ovaries and Polycystic Ovary Syndrome in lesbian women compared with heterosexual women
Fertility and Sterility, 2004; 82: 1352-1357.
- Randeva HS, Lewandowski KC, Drzewoski J, Prelevic GM
Exercise decreases plasma total homocysteine in overweight young women with Polycystic Ovary Syndrome
Journal of Endocrinology & Metabolism, 2002; 87: 4496-4501.
- Prelevic GM, P Kwong, DJ Byrne et al.
A cross-sectional study of the cardiovascular disease risk profile in heaqlthy postmenopausal women – differential effects of menopausal hormone replacement therapy
Fertility & Sterility, 2002; 77: 945-951.
- Brooke-Wavell K, Prelevic GM, Bartram C, Ginsburg J
Influence of physical activity on response of bone mineral density to 5 year tibolone
Maturitas, 2000; 35: 229-235.
- Agrawal R, Prelevic GM, Conway GS et al.
Serum vascular endothelial growth factor (VEGF) concentrations in postmenopausal women: The effect of hormone replacement therapy
Fertility & Sterility, 2000; 73: 56-60.
- Prelevic GM, Beljic T, Balint-Peric Lj, Ginsburg J
Metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes mellitus
Maturitas, 1998; 28: 271-276.
- Prelevic GM, Beljic T, Balint-Peric Lj, Ginsburg J
Cardiac flow velocity in women with Polycystic Ovary Syndrome
Clinical Endocrinology, 1995; 43: 677-681.
- Prelevic GM, Ginsburg J, Maletic D, et al.
The effects of the somatostatin analogue octreotide on ovulatory performance in women with Polycystic Ovary Syndrome
Human Reproduction, 1995; 10: 28-32.
- Prelevic GM & Beljic T
The effect of oestrogen and progestogen replacement therapy on systolic flow velocity in healthy postmenopausal women
Maturitas, 1994; 20: 37-44.
- Prelevic GM, Wurzburger MI, Balint-Peric Lj, Ginsburg J
Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in womens with Polycystic Ovary Syndrome
Hormone Research, 1992; 37: 125-131.
- Prelevic GM, Wurzburger MI, Balint-Peric Lj, Nesic JS
Inhibitory effect of Sandostatin on secretion of Luteinizing hormone and ovarian steroids in Polycystic Ovary Syndrome
The Lancet, 1990; 336: 900-903.